These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29891917)

  • 1. Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis.
    Mudireddy M; Gangat N; Hanson CA; Ketterling RP; Pardanani A; Tefferi A
    Blood Cancer J; 2018 Jun; 8(6):57. PubMed ID: 29891917
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.
    Rago A; Latagliata R; Montanaro M; Montefusco E; Andriani A; Crescenzi SL; Mecarocci S; Spirito F; Spadea A; Recine U; Cicconi L; Avvisati G; Cedrone M; Breccia M; Porrini R; Villivà N; De Gregoris C; Alimena G; D'Arcangelo E; Guglielmelli P; Lo-Coco F; Vannucchi A; Cimino G
    Leuk Res; 2015 Mar; 39(3):314-7. PubMed ID: 25636356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blastic crisis of primary myelofibrosis associated with multiple myeloblastomas ].
    Fukushima T; Uchida M; Iwasaki H; Kamiya K; Tanaka T; Yoshimura T; Sasaki K; Tsutani H; Wano Y; Takayama H
    Rinsho Ketsueki; 1990 Jan; 31(1):95-9. PubMed ID: 2313911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2014 Sep; 89(9):915-25. PubMed ID: 25124313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous extramedullary haematopoiesis associated with blast crisis in myelofibrosis.
    Pagerols X; Curc N; Martí JM; Vives P
    Clin Exp Dermatol; 1998 Nov; 23(6):296-7. PubMed ID: 10233634
    [No Abstract]   [Full Text] [Related]  

  • 6. Very poor outcome of leukemic transformation in myelofibrosis: a single center experience with 13 patients.
    Helbig G; Wieczorkiewicz-Kabut A; Pajak J; Wieclawek A; Stachowicz M; Soja A; Rusek A; Karolczyk A; Bartkowska-Chrobok A; Kyrcz-Krzemien S
    Leuk Lymphoma; 2012 Jun; 53(6):1236-8. PubMed ID: 22098404
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for leukemic transformation in patients with primary myelofibrosis.
    Huang J; Li CY; Mesa RA; Wu W; Hanson CA; Pardanani A; Tefferi A
    Cancer; 2008 Jun; 112(12):2726-32. PubMed ID: 18404742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemorrhagic infarction of the spleen in a patient with myelofibrosis, transforming to AML.
    Quinn JP; Bacon CL; O'Donnell JR; Murphy PT
    Eur J Haematol; 2004 Feb; 72(2):154. PubMed ID: 14962255
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F
    Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of acute myelogenous leukemia accompanied with myelofibrosis and megakaryocyte-like giant bizarre blasts].
    Yasunaga M; Hodohara K; Bamba F; Kitamura K; Fukuda M; Boku T; Miyagawa A; Inoue T; Kitoh K; Andoh A
    Rinsho Byori; 1995 Oct; 43(10):1078-82. PubMed ID: 8531394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelocytic leukemia with features simulating myelofibrosis with myeloid metaplasia.
    Krauss S
    Cancer; 1966 Sep; 19(9):1321-32. PubMed ID: 5223470
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells.
    Kimura A; Kawaishi K; Nakata Y; Hyodo H; Kuramoto A; Satow Y
    Leuk Lymphoma; 1995 Nov; 19(5-6):493-8. PubMed ID: 8590852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.
    Barosi G; Ambrosetti A; Centra A; Falcone A; Finelli C; Foa P; Grossi A; Guarnone R; Rupoli S; Luciano L; Petti MC; Pogliani E; Russo D; Ruggeri M; Quaglini S
    Blood; 1998 May; 91(10):3630-6. PubMed ID: 9572998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelofibrosis in a teenager. (A case report).
    Islam N; Mahtab H
    J Assoc Physicians India; 1972 Jun; 20(6):459-62. PubMed ID: 4511236
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis of Primary Myelofibrosis in the Genomic Era.
    Bose P; Verstovsek S
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S105-13. PubMed ID: 27521306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
    Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
    J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients.
    Morel P; Duhamel A; Hivert B; Stalniekiewicz L; Demory JL; Dupriez B
    Blood; 2010 Jun; 115(22):4350-5. PubMed ID: 20308601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathological and cytogenetic investigations of a case of myelofibrosis treated successfully with androgens].
    Pileri A; Masera P; Pegoraro L; Gavosto F
    Haematologica; 1966; 51(1):57-72. PubMed ID: 4956677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.